A quantitative real-time PCR high resolution melting (HRM) method for evaluating the O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status in malignant gliomas is superior to conventional methylation specific PCR in predicting clinical outcome and survival in patients with malignant glioma

Autor: Switzeny, Olivier J., Renovanz, Mirjam, Sommer, Clemens, Christmann, Markus, Giese, Alf, Kaina, Bernd
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Zdroj: 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC); 20150607-20150610; Karlsruhe; DOCP 040 /20150602/
DOI: 10.3205/15dgnc438
Popis: Objective: MGMT promoter status is an important prognostic factor in high-grade glioma patients and indispensable for decision making in neurooncological therapy. Currently, the MGMT promoter methylation is determined by methylation-specific PCR (MSP). The development of new approaches to improving [for full text, please go to the a.m. URL]
66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Databáze: OpenAIRE